Cargando…
Triphenylmethane Derivatives Have High In Vitro and In Vivo Activity against the Main Causative Agents of Cutaneous Leishmaniasis
The current standard of care for cutaneous leishmaniasis (CL) is organic antimonial compounds, but the administration of these compounds is complicated by a low therapeutic - toxic index, as well as parenteral administration. Thus, there is an urgent need for the development of new and inexpensive t...
Autores principales: | de Souza Pietra, Renata Celi Carvalho, Rodrigues, Lucas Fonseca, Teixeira, Eliane, Fried, Levi, Lefkove, Benjamin, Rabello, Ana, Arbiser, Jack, Ferreira, Lucas Antônio Miranda, Fernandes, Ana Paula |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3544846/ https://www.ncbi.nlm.nih.gov/pubmed/23341885 http://dx.doi.org/10.1371/journal.pone.0051864 |
Ejemplares similares
-
Pro-Apoptotic Activity of New Honokiol/Triphenylmethane Analogues in B-Cell Lymphoid Malignancies
por: Mędra, Aleksandra, et al.
Publicado: (2016) -
RESISTANCE OF BACTERIAL SPORES TO THE TRIPHENYLMETHANE DYES
por: Burke, Victor, et al.
Publicado: (1925) -
Removal of Triphenylmethane Dyes by Bacterial Consortium
por: Cheriaa, Jihane, et al.
Publicado: (2012) -
Triphenylmethane Dye Activation of Beta-Arrestin
por: Barak, Larry S., et al.
Publicado: (2013) -
Efficacy of pentavalent antimoniate intralesional infiltration therapy for cutaneous leishmaniasis: A systematic review
por: Brito, Nayara Castelano, et al.
Publicado: (2017)